一种多中心的卡斯特曼病与混合热和冷抗体介导的AHA相关,对西尔图西马布有反应

Federica Plano1, Salvatrice Mancuso1, Giulia Maria Camarda1

  • 1Department of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialties (PROMISE), University of Palermo, Palermo, Italy.

Chemotherapy
|August 27, 2023
PubMed
概括

卡斯特曼病 (MCD) 可能会出现难以诊断的自身免疫血清性贫血. 一种IL-6抑制剂Siltuximab有效地治疗了对标准疗法的耐药患者,实现了长期缓解.

相关概念视频